BioSpace News Archive

Drug Development

ImmunityBio Announces Positive Interim Phase I Safety Data of hAd5 T-Cell COVID-19 Vaccine Candidate in Oral and Sublingual Formulations

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced it has met the safety requirements for the first 12 participants in its Phase Ib human adenovirus (hAd5)-based T-cell COVID-19 vaccine trials in sublingual and oral formulations

March 15, 2021
·
8 min read
Policy

“No Student Debt,” US Gov Approves Biomedical Equipment Technician Apprenticeship

The U.S. Department of Labor has approved the creation of a modern apprenticeship program for prospective biomedical equipment technicians.

March 15, 2021
·
3 min read
BioMidwest

Researchers Unveil a New Theory Explaining Long-term Pain ReliefStimulation of peripheral nerves warrants consideration early in the care continuum

A novel theory recently published in the Journal of Pain Research proposes mechanisms by which a 60-day treatment using percutaneous peripheral nerve stimulation (PNS) may recondition the central nervous system (CNS) to restore normal pain processing and provide long-term pain relief for patients.

March 15, 2021
·
3 min read
Bio NC

Carolina Liquid Chemistries Corp. Becomes Value-Added Distributor for Mindray North America Hematology Systems

Carolina Liquid Chemistries Corp. announces its value-added distributorship for Mindray North America Hematology Systems.

March 15, 2021
·
2 min read